Drug Regulatory Authority of Pakistan likely to qualify for WHO recognition in next two years, Senate informed
ISLAMABAD: Minister for National Health Services Saira Afzal Tarar on Wednesday said that establishment of Drug Regulatory Authority of Pakistan is a progressive step and backed and supported by the professional and political leadership.
Responding to a calling attention notice in Senate regarding report of the World Health Organization on governance in the public pharmaceutical sector, the minister said that government has taken various steps to ensure transparency in the pharmaceutical sector.
Saira Afzal Tarar maintained that DRAP is likely to qualify for WHO recognition in next two years.
The minister said that Pakistan itself had requested the World Health Organization to evaluate gaps in its pharma sector. She said WHO report has also acknowledged Pakistan’s steps towards improving its management structure for medicines.
The minister explained that the agency is enduring transparency of medicines, governance and decreasing the vulnerability of the system to corruption.